[View Original Text]
On 9th of April, at the 15th Spring Academic Conference of the Korean Society of Obstetrics and Gynecology (direct translation), which was held at the Seoul Swiss Grand Hotel
Convention Center, AIDOT Co., Ltd. (represented by Jung Jae-hoon) announced their participation through their exclusive partner, the Korea Clinical Research Institute of the Korea
Foundation for the Promotion of Medical Science.
During the conference, AIDOT showcased their Cerviray AI system, a remote reading AI system for cervical cancer.
Attendees visited AIDOT's booth to learn about the innovative AI technology and its potential benefits for early cervical cancer screening, particularly those who were specialists in
obstetrics and gynecology.
AIDOT's Cerviray AI has not only received a Class 3 certification as an AI-based medical device from the Ministry of Food and Drug Safety, but also has completed commercialization
domestically and internationally, proving its excellence through various clinical data.
Jae-hoon Jeong, the CEO of AIDOT, emphasized the high accuracy of Cerviray AI, stating that the era of simply discussing AI with just the number of data is already over, and that "The performance of Cerviray AI is improving day by day as it learns and reflects meaningful clinical information from commercialization in many foreign countries." AIDOT, which has
expanded to various countries around the world, has also shown their determination to compete aggressively in the domestic market to bridge the gap with their competitors, not only for overseas women's health but also for promoting women's health in Korea.
Korean economy TV / 18th. Apr. 2023. / Reporter Joon Sik Park
Comments can be added by Member only